UPDATE 3-Ipsen seeks U.S. growth with $404 mln Tercica deal (Reuters, 5 June 2008)

16 Jun 2008


The French pharmaceutical company Ipsen, have announced they will be buying their American partner company, Tercica Inc, for $404 million.

Full article


Hormones in the News